Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

Panacea Biotec surges 4% on reports of launching dengue vaccine in two yrs

Shares of Panacea Biotec surged up to 4.48 per cent at Rs 319.40 on the BSE in Friday's intraday trade

By: business-standard.com

Oct 11 2024
0
0 Views

Panacea Biotec surges 4% on reports of launching dengue vaccine in two yrs

Panacea Biotec surges 4% on reports of launching dengue vaccine in two yrs

Related

Bondada Engg gains on bagging multiple orders worth Rs 1,132-cr

Usha Martin Ltd leads gainers in 'A' group

India committed to strengthening Comprehensive Strategic Partnership with ASEAN

Exide Ind up 4% as it invests over Rs 99 crore in arm Exide Energy

Ashoka Metcast Ltd leads gainers in 'B' group

Sansera Engg gains on launching QIP; floor price at Rs 1,635.48/share

Why have BSE shares climbed 4% on October 11? Check reasons here

Rupee breaches 84 mark against US dollar as FPIs pull out of equities

Container Corporation of India announces change in CFO

Mazagon Dock bags Rs 122-cr order from MAHAGENCO

Ahluwalia Contracts bags contract worth Rs 1,095 crore from DLF City Centre

Panacea Biotec surges 4% on reports of launching dengue vaccine in two yrs

Bondada Engg gains on bagging multiple orders worth Rs 1,132-cr